Home  /  Resource Library  /  ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

Results of a phase III study investigating lenalidomide combined with chemoimmunotherapy for first line treatment of diffuse large b-cell lymphoma with activated b-cell subtype.